Sucheta More

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 421 citations

Medicine, Oncology, Pharmacology +15

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Vijay Patil, Vanita Noronha, Amit Joshi et al. · ESMO Open · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2019 · 28 citations

Medicine, Oncology, Pharmacology +6

Reasons for Initiation of Areca Nut and Related Products in Patients with Oral Submucous Fibrosis within an Endemic Area in Gujarat, India

Chandramani B. More, Naman R. Rao, Sucheta More et al. · Substance Use & Misuse · 2020 · 25 citations · Full text

Dentistry, Dental Public Health, Oral Health Sciences +14

Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC

Vichitra Behel, Anuradha Chougule, Vanita Noronha et al. · Clinical Lung Cancer · 2022 · 13 citations

Medicine, Clinical Sciences, Oncology +17